tradingkey.logo
tradingkey.logo
Buscar

Prenetics Global Ltd

PRE
Añadir a la lista de seguimiento
16.930USD
-0.960-5.37%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
287.82MCap. mercado
PérdidaP/E TTM

Más Datos de Prenetics Global Ltd Compañía

Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.

Información de Prenetics Global Ltd

Símbolo de cotizaciónPRE
Nombre de la empresaPrenetics Global Ltd
Fecha de salida a bolsaJul 06, 2021
Director ejecutivoKwok (Samantha)
Número de empleados285
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 06
DirecciónUnit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay
Ciudad
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísHong Kong
Código postal- -
Teléfono85222109588
Sitio Webhttps://ir.prenetics.com/
Símbolo de cotizaciónPRE
Fecha de salida a bolsaJul 06, 2021
Director ejecutivoKwok (Samantha)

Ejecutivos de Prenetics Global Ltd

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Co-Founder, Chief Scientific Officer
Co-Founder, Chief Scientific Officer
--
--
Mr. Hoi Chun (Stephen) Lo
Mr. Hoi Chun (Stephen) Lo
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--
Dr. Yung Ho (Peter) Wong
Dr. Yung Ho (Peter) Wong
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Joel Neoh
Mr. Joel Neoh
Chief Consumer Officer, Chief Executive Officer of CircleDNA
Chief Consumer Officer, Chief Executive Officer of CircleDNA
--
--
Ms. Kathryn Henry
Ms. Kathryn Henry
Independent Director
Independent Director
--
--
Mr. David Vanderveen
Mr. David Vanderveen
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Co-Founder, Chief Scientific Officer
Co-Founder, Chief Scientific Officer
--
--
Mr. Hoi Chun (Stephen) Lo
Mr. Hoi Chun (Stephen) Lo
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Prenetics Global Ltd?

Los cinco principales accionistas de Prenetics Global Ltd son: Mr. Sheng Wu (Danny) Yeung

¿Cuántas instituciones poseen acciones de Prenetics Global Ltd (PRE)?

A fecha de 2026Q1, 46 instituciones poseen acciones de Prenetics Global Ltd, con un valor de mercado combinado de aproximadamente 1.76M, lo que representa el 11.33% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -778478.00.